Investment Opportunities
in Lille-Region – France
EURASANTE
The Economic Development Agency
dedicated to Healthcare, Nutrition
and Biotech activities in Northern
France
2
Key facts
• Eurasanté was built following Lille’s CHRU CEO’s vision (to reactivate the
region’s economy by leaning upon a company’s know-how and expertises)
and the elected representatives’ will to make healthcare market a real
driving force behind the region’s economical development
• 1994 Eurasanté was created
• 1996 Creation of Eurasanté Bio-business Park
• 1999 Eurasanté Bio-Incubator certification
• 2005 Nutrition Health Longevity Cluster certification
• 2006-2009 Important companies such as Tate & Lyle, Glaxo Smith Kline,
Bayer Healthcare are establishing themselves in Northern France
• 2013 Constitution of the SIRIC ONCOLILLE, the Excellence Center in
3
Cancer labellised by the French National Institute of Cancer
Eurasanté is dedicated to…
40 co-workers managing and monitoring :
• Northern France companies
• Scientists and Clinicians willing to add economical value out of their
researches
• Foreign companies willing to set-up their business in the Lille-Nord-Pas
de Calais Region
Healthcare, Nutrition and Biology sector in Northern France
in 2013 represent :
• 765 companies
(642 companies in 2002)
• A 7,12 billion euros turnover
(5.5 billion € in 2002)
• 23 000 employees
(17 670 employees in 2002)
4
Territorial assets…
At the heart of European markets…
Some key facts
• 4 million inhabitants,
London
Brussels
• 155 000 students,
• The largest university-hospital campus in Europe,
Paris
• 1 800 researchers in healthcare, biology and nutrition
• 800 companies in healthcare and biology, with well-known expertises
such as : Nutrition and functional ingredients, Pharma Biotech, Blood
related activities…
5
Markets & technologies of the
Healthcare sector : Regional
strengths





Nutrition and functional ingredients,
Cardiometabolic diseases,
Neurodegenerative diseases,
Blood related activities,
Medicinal chemistry
6
Success indicators
Eurasanté’s Bio-Business Park has become the biggest university-hospital campus in
Europe, entirely dedicated to Health actors :
Eurasanté’s Bio-Incubator helped and supported 80 projects since 2000
The competitiveness cluster’s certification, THE NHL CLUSTER
In order to bring original answers to obesity, diabetes, high blood pressure and
Alzheimer’s disease.
EGID (European Genomic Institute for Diabetes) is the first institute in France dedicated
to diabetes and its complications
MEDIALZ aims to create a reference centre in order to accelerate research on Alzheimer’s
disease and optimize the delivery of research outcomes to patients.
7
Eurasanté Bio-Incubation :
welcoming the first steps of
innovative start-ups
 The Eurasanté bioincubator offers - within the Eurasanté
Bio-Business Park - 2 000 sqm state-of-art building including
laboratories, offices and shared facilities.
 Pre-seed Financing tool (100 K€ per project to carry out
studies to reinforce project feasibility at scientific, technical,
legal and financial levels, etc.) and seed tools (1 M€)
available.
-
97 projects supported since 2000
-
59 companies created
-
More than 400 jobs created
-
More than 120 ME raised
8
Eurasanté supports a
Competitiveness Cluster
The Nutrition Health Longevity Cluster (Lille – Northern
France) brings together agrifood industries, biotech
companies and academic researchers with the objective to
set up collaborative projects in the field of :
 Prevention and treatment of multifactorial chronic
pathologies
- Almost 80 members
- Since early 2006, 180
collaborative projects have
been certified , for a total R&D
budget of more than 300M€
 Development of functional ingredients and foods
 Development of innovative therapeutic & diagnostic
solutions
9
Eurasanté Bio-business Park
View, planned construction and set up projects
Eurasport
Diagast
Bio-Incubator
Ext. School of
LFB
Medicine
The
UniversityHospital
Center of
Lille
M Subway Station
Genfit
School of
Medicine
Santélys
A
B2
School of
Pharmaceutical
Sciences
Biolume
Bayer
French Blood
Establishment
HMS
5
6B
F1/F2
F
School of Visually
Impaired People
G
H
Building permit
-F1/F2 : Hotel and offices
High frequency
bus line
Available land
Set up projects
Planned construction
Sogiphar
Pharmavision
Eurasanté Bio-business Park
135 health related companies and organisations employing 2 700 people
− 25% Medical devices and hospital engineering
− 25% Specialised services
− 20% Biotechnology, pharma and nutrition
− 10% Higher education and training
− 8% Public health organisations
− 7% Medical care network
− 5% IT applied to health
At the heart of the first university-hospital campus in Europe which hosts
12 000 students and 14 000 health professionals
− The University-Hospital Centre of Lille (7 establishments)
− Medecine, pharmacy, dental surgery and health
engineering faculties
− Paramedical training courses in physiotherapy, osteopathy,
ergotherapy and psychomotricity
− 2 nursing schools
A centre of excellence over 300 hectares devoted to innovative industries in
the field of health and life sciences
Financed by
European Union
European Regional Development Fund